In This Article:
Charlotte's Web Holdings (TSE:CWEB) Full Year 2024 Results
Key Financial Results
-
Revenue: US$49.7m (down 21% from FY 2023).
-
Net loss: US$29.8m (loss widened by 25% from FY 2023).
-
US$0.19 loss per share (further deteriorated from US$0.16 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Charlotte's Web Holdings Earnings Insights
In the last 12 months, the only revenue segment was Hemp-Based, CBD Wellness Products contributing US$49.7m. Notably, cost of sales worth US$28.4m amounted to 57% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$41.6m (78% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of US$2.14m. Explore how CWEB's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 2.0% p.a. on average during the next 2 years, compared to a 7.4% growth forecast for the Pharmaceuticals industry in Canada.
Performance of the Canadian Pharmaceuticals industry.
The company's shares are up 7.4% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Charlotte's Web Holdings has 4 warning signs (and 1 which is a bit unpleasant) we think you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.